BioCopper1 for Gray Hair and Skin Health
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to investigate the efficacy of BioCopper1®, Restore Cu1, and Grow + Restore Cu1 on grey hair, hair growth, and/or skin improvements in healthy adults. The main question it aims to answer is: what is the change from baseline to Day 168 in percentage of grey hair between BioCopper1®, Restore Cu1, or Grow + Restore Cu1 and placebo, as assessed by HairMetrix? Researchers will compare the investigational products to a placebo to determine their effectiveness. Participants will be asked to:
* Have their blood pressure, heart rate, height, and weight measurements taken
* Have their blood samples collected
* Complete questionnaires and a study diary
* Be assessed using the VISIA imaging system, Corneometer, and Cutometer
* Consume BioCopper1®, Restore Cu1, Grow + Restore Cu1, or placebo
Are You a Good Fit for This Trial?
This trial is for healthy adults interested in improving gray hair, hair growth, or skin health. Participants should be generally healthy and willing to take study supplements and undergo regular check-ups and assessments.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- BioCopper1®
- Grow + Restore Cu1
- Restore Cu1
Trial Overview
The study tests three products—BioCopper1®, Restore Cu1, and Grow + Restore Cu1—against a placebo to see if they improve gray hair, hair growth, or skin quality over about six months. Participants are randomly assigned to one of the groups.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Placebo Group
Starting the day following their baseline B visit (Day 1), participants will be instructed to take one dose (one capsule) with water twice daily with or without food until the day prior to their end of study visit (Day 167). Participants will be instructed to not take any zinc or N-acetylcysteine supplements within 4 hours of dose.
Starting the day following their baseline B visit (Day 1), participants will be instructed to take one dose (one capsule) with water twice daily with or without food until the day prior to their end of study visit (Day 167). Participants will be instructed to not take any zinc or N-acetylcysteine supplements within 4 hours of dose.
Starting the day following their baseline B visit (Day 1), participants will be instructed to take one dose (one capsule) with water twice daily with or without food until the day prior to their end of study visit (Day 167). Participants will be instructed to not take any zinc or N-acetylcysteine supplements within 4 hours of dose.
Starting the day following their baseline B visit (Day 1), participants will be instructed to take one dose (one capsule) with water twice daily with or without food until the day prior to their end of study visit (Day 167). Participants will be instructed to not take any zinc or N-acetylcysteine supplements within 4 hours of dose.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mitosynergy LLC
Lead Sponsor
KGK Science Inc.
Industry Sponsor
Najla Guthrie
KGK Science Inc.
Chief Executive Officer since 1997
Research career at the Centre for Human Nutrition, University of Western Ontario
Dr. Bibiane Zakaria
KGK Science Inc.
Chief Medical Officer since 2023
MD from an unspecified institution
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.